About GaBI
GaBI is a Healthcare company. It operates as a providing information on generics and biosimilars in the pharmaceutical industry. GaBI offers products and services including Generics Information and Biosimilars Information. Its focus areas include Pharmaceuticals, Generics, Generic Drugs and Biotechnology. Its legal entity is Generics and Biosimilars Initiative.
Company details
The Generics and Biosimilars Initiative is known for disseminating information on cost-effective treatments through various editorial sections that cover news, research, and guidelines on generic and biosimilar medicines. Topics such as FDA and EMA approvals, global market trends, and policy developments are highlighted to enhance understanding of pharmaceutical advancements. Efforts to address drug shortages and promote access in low- and middle-income countries are also featured, contributing to trust in these treatments across regions like Europe, the US, and Latin America.
Products & Services of GaBI
GaBI offers a comprehensive portfolio of products and services, including Generics Information and Biosimilars Information.
Information on generic drugs is disseminated through news articles and research studies that cover approvals and market trends.
Information on biosimilars is provided via editorial sections that include approvals, research, and general insights into biotechnology developments.
Web traffic of GaBI
Websites that share an audience with GaBI (gabionline.net).
Websites whose visitors overlap most with GaBI. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| navamedic.com | 100% | 12.9K | #3,740,020 | View details | |
| zentiva.com | 100% | 9.9K | #2,071,369 | View details | |
| eversana.com | 91% | 38.7K | #636,017 | View details | |
| sandoz.com | 80% | 195.3K | #232,061 | View details | |
| celltrion.com | 70% | 179.3K | #287,455 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for GaBI
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as GaBI (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about GaBI
The Generics and Biosimilars Initiative is known for disseminating information on cost-effective treatments through various editorial sections that cover news, research, and guidelines on generic and biosimilar medicines. Topics such as FDA and EMA approvals, global market trends, and policy developments are highlighted to enhance understanding of pharmaceutical advancements. Efforts to address drug shortages and promote access in low- and middle-income countries are also featured, contributing to trust in these treatments across regions like Europe, the US, and Latin America.
GaBI offers Generics Information and Biosimilars Information.
GaBI operates through Generics And Biosimilars Initiative.